Mediators of diabetic neuropathy: is hyperglycemia the only culprit? - Wikidata - awgldk - TriplyDB

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

http://www.wikidata.org/entity/Q39015184

about

Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Impact of Normoglycemia in Reducing Microvascular Complications in Patients with Type 2 Diabetes: A Follow-Up Study.Gene Polymorphism in Indonesian Subjects with Diabetic Polyneuropathy

P2860

Q49385295-5BEB583D-EFFB-43DF-BA71-301789FCD18C Q51739538-F1BB54C8-D818-40AA-9229-4B6AEE7C6103 Q59136710-B2357B80-7CD2-4CB2-A6CC-AA9B44A9D5F6

P2860

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

http://www.wikidata.org/entity/Q39015184

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@en

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@nl

type

label

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@en

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@nl

prefLabel

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@en

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@nl

P1433

Q39015184-C38E2F4C-024B-492B-AA98-7A3CA31278E4

P1476

Q39015184-7F3C6549-8BBC-4C92-B609-51D6E891BB2C

P2093

Q39015184-6E08382B-F2F6-438E-9B59-C58316755303

Q39015184-717867DA-3D25-47A0-BB97-84BDB6DB5A53

P2860

Q39015184-005DDC2A-3A5C-4691-A0FC-03EF9B60276F

Q39015184-00F3DFFC-5F67-41EB-8964-8353819B41B7

Q39015184-0337EC18-3C75-47C4-B82E-02F8F7BEFF9B

Q39015184-040BCDD0-DA92-4841-97E8-C456A40F74E8

Q39015184-05B99C0A-4967-41A9-AAC8-43C548CE49B7

Q39015184-10865956-6B8B-4A3F-B539-F704832ED24E

Q39015184-18766A58-7852-4186-A7C6-75989A174FBD

Q39015184-1D3E1A7D-04BE-450F-B0C1-59EFD0EFB7D6

Q39015184-2006A1C8-0754-4D18-BCE4-EE6ADEB9F85E

Q39015184-23404A20-97B1-4C54-B84A-DB4402E203CB

P304

Q39015184-CF63C453-5BD2-46D5-BEB2-0697A20D1D8C

P31

Q39015184-C2897E32-DEF5-42E3-856A-D03F366D7A7F

P356

Q39015184-CE2BC237-DFA3-42F3-B6C6-B4EF6593303F

P433

Q39015184-BD8AB108-D10B-4CD2-AD47-98F859C2C7F5

P478

Q39015184-CA7DA9E7-A871-4096-AC34-11ADF05CF3C4

P50

Q39015184-63057619-6533-4B25-ADEF-0FF9B618047D

P577

Q39015184-E35C9535-C401-428F-8AB5-36A7AB2CFCDD

P698

Q39015184-8EDC1357-FFBE-4B27-A123-14191A943E41

P921

Q39015184-F8188232-10B8-4C71-B9ED-DA1F24138325

P932

Q39015184-9B1B6D33-8F53-46C8-8DF8-E03F6C0C6C6A

P356

MED.0000000000000320

P1433

Current Opinion in Endocrinology, Diabetes and Obesity

P1476

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

@en

P2093

Anna Grisold

http://www.w3.org/2001/XMLSchema#string

Brian C Callaghan

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced glucose control for preventing and treating diabetic neuropathy

The epidemiology and risk factors of chronic polyneuropathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo

Glucose control and vascular complications in veterans with type 2 diabetes

Diabetic neuropathy: mechanisms to management

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study.

Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients.

Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome.

P304

103-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MED.0000000000000320

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28098594

http://www.w3.org/2001/XMLSchema#string

P921

P932

5831542

http://www.w3.org/2001/XMLSchema#string